Photon Therapeutics, a veterinary device company, is pleased to announce the appointment of Dr Mark Leddy BVSc MBA MRCVS as its new CEO.
Dr Leddy brings extensive experience to the role, having previously served as Managing Director of TVM UK, where he successfully led the UK operations for Domés Pharma and played a key role in the launch of several new products.
As Photon Therapeutics prepares to introduce its new innovation to the UK market, Dr Leddy expressed his enthusiasm for the opportunities ahead.
‘This is an incredibly exciting time for Photon Therapeutics, and I am delighted to be leading the launch of this cutting-edge technology. I believe that in the coming years, our product will become a vital component in veterinary ophthalmology treatment plans, and I’m excited to see where this journey will take us.’
The Photon Therapeutics device will be launched at London Vet Show in November 2024.
